WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Xi Says China, U.S. Sister Cities Cooperation FruitfulScenery of BandXi Focus: Key Takeaways from Xi's Meetings with Foreign GuestsRole of finance in industrial upgrade gets experts' attentionWorld Volkswagen Day celebration held in ColomboVessels made in Fujian take semisubmersible ride to boost BRI tiesMultilingual Alipay to enhance foreigners' eAlibaba to invest $640m in HK's entertainment industryForeign retailers buoyant on Chinese marketApple opens its eighth store in Shanghai